Luciana Griebel

Morgan Lewis

+ Follow Contact

Latest Posts › Biotechnology

Share:

UK Life Sciences Sector Plan: What In-House Legal and Compliance Teams Need to Know

The UK government recently unveiled its 10-year Life Sciences Sector Plan, putting forward a comprehensive strategy for transforming the UK into a global leader in life sciences by 2035. This LawFlash outlines key areas of...more

7/23/2025 / Biotechnology , Clinical Trials , Data Privacy , Intellectual Property Protection , Investment , Life Sciences , Merger Controls , Regulatory Reform , UK

M&A Considerations Across the Evolving Life Sciences Sector: Key Takeaways

In the latest installment of the Morgan Lewis M&A Academy, partners Laurie Burlingame and Luciana Griebel provided an overview of current market trends in mergers and acquisitions (M&A) and strategic partnerships within the...more

4/2/2025 / Acquisitions , Biotechnology , Drug Pricing , Due Diligence , Foreign Investment , Intellectual Property Protection , Life Sciences , Mergers , Pharmaceutical Industry , Regulatory Requirements

Key Takeaways from the 2025 JP Morgan Healthcare Conference

Several members of our firm’s life sciences team were on the ground at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco from January 13 to 16, 2025. It was an exciting and sunny four days, during which key...more

2/3/2025 / Acquisitions , Artificial Intelligence , Biotechnology , Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Food and Drug Administration (FDA) , Investment , Life Sciences , Mergers , Pharmaceutical Industry

3 Results

View per page

Page: of 1